Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial
Resource Type
Article
Authors
Prat, Aleix ; Saura, Cristina ; Pascual, Tomás ; Hernando, Cristina ; Muñoz, Montserrat ; Paré, Laia ; González Farré, Blanca ; Fernández, Pedro L ; Galván, Patricia ; Chic, Núria ; González Farré, Xavier ; Oliveira, Mafalda ; Gil-Gil, Miguel ; Arumi, Miriam ; Ferrer, Neus ; Montaño, Alvaro ; Izarzugaza, Yann ; Llombart-Cussac, Antonio ; Bratos, Raquel ; González Santiago, Santiago ; Martínez, Eduardo ; Hoyos, Sergio ; Rojas, Beatriz ; Virizuela, Juan Antonio ; Ortega, Vanesa ; López, Rafael ; Céliz, Pamela ; Ciruelos, Eva ; Villagrasa, Patricia ; Gavilá, Joaquín
Source
In The Lancet Oncology January 2020 21(1):33-43
Subject
Primary Research Articles
Language
ISSN
1470-2045